The earnings call presented a mixed outlook: while there are positive elements like raised EBITDA guidance and strategic investments for growth, there are also concerns. Revenue is projected to decline, tariffs will impact costs, and management avoided specifics on key growth metrics. The Q&A highlighted uncertainties, particularly around investment impacts and comp stabilization, suggesting cautious sentiment. The lack of a clear timeline for recovery and the influence of tariffs contribute to a neutral rating.